PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Conditions

• Prostate Cancer
• Metastatic Castration-resistant Prostate Cancer

Interventions

• DRUG: 89Zr-DFO-YS5
• BIOLOGICAL: YS5 antibody
• PROCEDURE: Positron Emission Tomography (PET)/Computerized tomography (CT)
• PROCEDURE: Positron Emission Tomography (PET)/Magnetic Resonance Imaging (MRI)

Sponsor

Robert Flavell, MD, PhD

Collaborators

• [object Object]
• [object Object]